Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederesmo.org
ESMO News
Get the latest updates from ESMO News directly as they happen.
Follow now 79 followers
Latest posts
Last updated about 13 hours ago
Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence
about 13 hours ago
Findings from the LITESPARK-022 study
Aiming to Improve Cancer Prevention, ESMO Calls for Strong Policy Measures to Fight the Tobacco Epidemic in Feedback on the EU Tobacco Products and Advertising Legislation
1 day ago
Given that up to 40% of all cancers are preventable, robust tobacco...
Temporary Interruption of Endocrine Therapy for Pregnancy, Including Use of Fertility Preservation, Does Not Increase Risk of Breast Cancer Events in Women with HR-positive Breast Cancer
1 day ago
Updated findings from the POSITIVE study
EMA Recommends Extension of Therapeutic Indications for Pembrolizumab
5 days ago
New indications concern treatment of adult patients with resectable muscle invasive bladder...
CD19-Directed CAR T-Cell Therapy Leads to Exceptionally Long Remissions in Some Patients with Relapsed or Refractory B-Cell non-Hodgkin Lymphomas
6 days ago
Findings from 10-year follow-up of a phase II study
The European Parliament’s Reports Include Several ESMO Asks and Materially Strengthen the European Commission Proposals Under the ‘Health Package’
7 days ago
Proposed changes to the EU in vitro diagnostic medical devices (IVDR) legislation...
ESMO Welcomes the WHO Global Status Report on Cancer with Key Recommendations for Equitable Cancer Care
7 days ago
ESMO hails the publication of the WHO Global Status Report on Cancer...
FDA Approves Capivasertib with Abiraterone and Prednisone for PTEN-deficient Androgen Pathway Modulation-Naïve or -Sensitive Prostate Cancer
7 days ago
It also approved a companion diagnostic device
Lorlatinib Continues to Show Long-Term Benefit in Newly-Diagnosed Patients with Advanced ALK-positive NSCLC
8 days ago
Findings after 7 years of follow-up in the CROWN study
GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes
9 days ago
Findings from a large real-world cohort
EMA Recommends Extension of Therapeutic Indications for Sacituzumab Govitecan
12 days ago
New indication concerns monotherapy for patients with advanced TNBC who have not...
Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma
13 days ago
Findings from the SUCCESSOR-2 study